Free Stock & ETF Comparisons

Compare Amgen and AbbVie by biosimilar portfolio depth, Humira replacement revenue, oncology pipeline, dividend yield sustainability, and long-term earnings power.

Compare Intuitive Surgical and Stryker by da Vinci procedure growth, Mako robotic surgery adoption, recurring instrument revenue, margins, and long-term medtech value.

Compare Dexcom and Abbott Laboratories by continuous glucose monitor market share, G7 vs FreeStyle Libre accuracy, sensor wear time, gross margin, and GLP-1 competitive risk.

Compare HCA Healthcare and Tenet Healthcare by same-facility revenue growth, ambulatory surgery center mix, payer mix, free cash flow, and analyst upside.

Compare UnitedHealth Group and Elevance Health by Optum services revenue, Medicare Advantage membership, medical loss ratio, earnings growth, and relative valuation.

Compare Cigna and UnitedHealth by pharmacy benefits management revenue, Optum vs Evernorth services, employer vs government program mix, and valuation.

Compare Moderna and Novavax by mRNA platform breadth vs protein-subunit differentiation, COVID vaccine revenue decline, flu and RSV pipeline, cash runway, and upside.

Compare Regeneron and Moderna by Dupixent/Eylea revenue durability vs next-generation vaccine pipeline, oncology programs, gross margin, and long-term biotech value.

Compare Caterpillar and CNH Industrial by mining vs agricultural machinery mix, autonomous equipment investment, Services revenue, margins, and dividend policy.

Compare Deere & Company and AGCO Corporation by precision agriculture technology, dealer network breadth, services revenue, cycle recovery timing, and valuation.

Compare Honeywell and Emerson Electric by portfolio transformation strategy, automation software revenue, aerospace mix, dividend growth track record, and relative valuation.

Compare 3M and Honeywell by litigation resolution progress, portfolio restructuring, aerospace exposure, dividend sustainability after cut, and analyst upside.

Compare XPO and Old Dominion Freight Line by service quality reputation, network density, operating ratio improvement, market share gains, and analyst upside.

Compare CSX and Union Pacific by intermodal volume growth, pricing power, fuel surcharge revenue, dividend growth, operating efficiency, and valuation.

Compare Norfolk Southern and Union Pacific by coal volume exposure, intermodal competitive dynamics, post-derailment recovery, operating ratio, and analyst upside.

Compare Boeing and Airbus by commercial aircraft backlog, production ramp execution risk, 737 MAX certification status, defense contracts, and valuation recovery potential.

Compare Republic Services and Waste Management by landfill gas-to-energy investment, recycling revenue, pricing power, dividend growth, and long-term return on capital.

Compare Vulcan Materials and Martin Marietta by aggregates pricing power, IIJA infrastructure spending leverage, quarry reserve quality, margins, and analyst upside.

Compare NVIDIA and Alphabet by GPU dominance vs TPU internal capability, cloud AI infrastructure revenue, CUDA ecosystem lock-in, and which company wins the AI compute race.

Compare TSMC and Intel by foundry market share, Intel 18A node progress, customer loyalty, geopolitical risk, margins, and which semiconductor giant is the better investment.

Compare ARM Holdings and Intel by Windows-on-Arm adoption, server CPU market share, royalty vs product revenue model, AI PC exposure, and valuation.

Compare Marvell Technology and AMD by hyperscaler custom ASIC traction, GPU/CPU AI revenue, data center networking, margin profile, and forward valuation.

Compare Broadcom and Marvell Technology by hyperscaler custom silicon revenue, networking chip breadth, software revenue mix, margin structure, and analyst upside.

Compare ON Semiconductor and Analog Devices by EV silicon carbide revenue vs industrial automation analog, margin structure, inventory cycle exposure, and valuation.

Compare NXP Semiconductors and ON Semiconductor by automotive microcontroller market share, EV content per vehicle, silicon carbide exposure, dividend, and valuation.

Compare NXP Semiconductors and Qualcomm by automotive ADAS revenue, vehicle compute platform design wins, 5G vs car connectivity exposure, and analyst upside.

Compare Teradyne and KLA Corporation by chip test vs process control market, robotics automation revenue, NAND recovery leverage, and long-term margins.

Compare Wolfspeed and ON Semiconductor by silicon carbide wafer capacity, EV OEM design wins, path to profitability vs established margins, and investment risk/reward.

Compare Palantir and BigBear.ai by government contract depth, commercial AI revenue, platform differentiation, cash generation vs burn rate, and long-term AI platform value.

Compare Upstart and Affirm by personal vs point-of-sale loan origination, AI credit model performance across cycles, funding partner dependency, and upside potential.

Compare SoundHound AI and Apple by voice recognition market penetration, restaurant and automotive AI deployment, Siri vs third-party capabilities, revenue scale, and risk.

Compare Snowflake and MongoDB by data warehouse vs document database architecture, AI vector search adoption, consumption vs subscription model, and forward valuation.

Compare Datadog and Cisco (which acquired Splunk) by pure-play observability growth vs integration risks, AI-driven log analysis, net revenue retention, and valuation.

Compare Veeva Systems and IQVIA by CRM and vault platform stickiness vs clinical data analytics revenue, pharma customer concentration, growth rate, and valuation.

Compare SAP and Oracle by cloud ERP migration progress, database licensing revenue, AI product roadmaps, operating margin expansion, and relative valuation.

Compare Microsoft and Oracle by Azure vs OCI cloud growth, AI product suite depth, enterprise customer switching costs, operating margin, and relative valuation.

Compare Zendesk (acquired by Permira but with public comparables) and Salesforce by AI-powered customer service automation, ticket deflection ROI, enterprise expansion, and moat.

Compare AppLovin and Unity Software by AI-powered ad targeting revenue, mobile gaming install volume, gross margin, profitability trajectory, and analyst upside.

Compare Eli Lilly and Novo Nordisk by tirzepatide vs semaglutide market share, oral GLP-1 pipeline, manufacturing capacity, and which obesity drug leader is the better investment.

Compare Biogen and Regeneron by Leqembi Alzheimer's revenue ramp, Dupixent indication expansion, pipeline depth beyond core franchises, and long-term biotech value.

Compare AbbVie and Eli Lilly by dividend income vs capital appreciation potential, Skyrizi/Rinvoq vs Mounjaro/Zepbound revenue trajectory, pipeline depth, and valuation.

Compare Sarepta Therapeutics and BioMarin Pharmaceutical by Duchenne muscular dystrophy vs hemophilia gene therapy revenue, regulatory pathway, and long-term orphan drug moat.

Compare Peloton and Nike by connected fitness subscription revenue, brand strength in digital health, turnaround execution, operating margin potential, and valuation.

Compare Teladoc Health and Amwell by BetterHelp mental health revenue, enterprise telehealth adoption, path to breakeven, subscriber retention, and long-term digital health value.

Compare Intuitive Surgical and GE HealthCare by procedure volume growth, Edison AI platform revenue, recurring consumables mix, margin expansion, and valuation.

Compare Humana and Molina Healthcare by Medicare Advantage enrollment growth, Medicaid redetermination impact, medical loss ratio, earnings visibility, and analyst upside.

Compare Alexandria Real Estate and Equinix by life science campus NOI growth, AI-driven data center demand, tenant quality, AFFO yield, and which specialty REIT wins.

Compare Digital Realty Trust and Iron Mountain by AI hyperscale demand, data management software pivot, dividend growth, lease structure, and long-term REIT value.